[reuters.com – 2021.110.05] Pfizer Inc’s experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said on Friday, as its CEO vowed to make this promising new weapon in the fight against the pandemic available globally as quickly as possible. The […]
Pfizer says its antiviral pill slashes risk of severe COVID-19 by 89% Read More »
[reuters.com – 2021.11.04] Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc (MRK.N) and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, for
Britain approves Merck’s COVID-19 pill in world first Read More »
[CNBC.com – March 23, 2021] Pfizer said Tuesday it has begun an early stage clinical trial of an experimental oral antiviral drug for Covid-19. The New York-based company said the phase one trial of the drug – called PF-07321332 – is being conducted in the United States. The drug is part of a class of
Pfizer begins human trials for pill that could treat Covid-19 Read More »
[Fox8.com – March 7, 2021] A COVID-19 treatment in pill form is being developed and results have shown early promise for the drug to be like Tamiflu for the pandemic. Pharmaceutical company Merck & Co. and biotechnology partner Ridgeback Biotherapeutics announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind, placebo-controlled trial to evaluate the safety,
New pill shows ‘promising signs of effectiveness’ in treating COVID-19 Read More »